ResearcherGuiyang Medical UniversityActive in the last 2 years
Songbai Liu
Matched on ORCID iD 0000-0002-3920-1032; OpenAlex author ID A5034308934. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: 4 papers · 2024: 2 papers
Papers 7
- TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic canc… Co-author DOI 10.1016/j.cellsig.2024.111227↗
- PELI1: key players in the oncogenic characteristics of pancreatic Cancer. Co-author DOI 10.1186/s13046-024-03008-9↗
- FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Co-author DOI 10.18632/aging.204780↗
- Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Co-author DOI 10.18632/aging.205071↗
- The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR sig… First author DOI 10.3389/fonc.2023.1169833↗
- Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Co-author DOI 10.3892/ol.2023.13871↗
- FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. Co-author DOI 10.1038/s41420-022-01047-9↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yaozhen Pan · 7 shared papers, 2022–2024 · strength 1.32
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9↗
- Paper Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics appro… DOI 10.3892/ol.2023.13871↗
- Xiaobin Fei · 6 shared papers, 2023–2024 · strength 1.15
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9↗
- Paper Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics appro… DOI 10.3892/ol.2023.13871↗
- Peng Liu · 3 shared papers, 2022–2024 · strength 0.55
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9↗
- Paper FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. DOI 10.1038/s41420-022-01047-9↗
- Paper Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation o… DOI 10.18632/aging.205071↗
- Likun Ren · 2 shared papers, 2024 · strength 0.42
- Xing Wang · 2 shared papers, 2024 · strength 0.42
- Yongjia Gao · 2 shared papers, 2024 · strength 0.42
- Zhiwei He · 2 shared papers, 2023 · strength 0.34
- Paper FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiqui… DOI 10.18632/aging.204780↗
- Paper Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation o… DOI 10.18632/aging.205071↗
- Peng Liu · 1 shared paper, 2023 · strength 0.18
- Yongning Li · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.